secwatch.observer — SEC 8-K summary
======================================

Issuer:     HARVARD BIOSCIENCE INC (HBIO)
CIK:        0001123494
Form:       8-K
Filed at:   2023-03-10T23:59:59+00:00
Accession:  0001171843-23-001577
Event type: other
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Harvard Bioscience approves 2023 cash incentive plan for CEO and Interim CFO
----------------------------------------------------------------------------

- Compensation Committee approved 2023 annual cash incentive plan on March 6, 2023.
- CEO and Interim CFO receive target award as a percentage of 2023 base salary.
- Payout can range from 0% to 150% of target based on corporate financial objectives.
- No specific targets, dollar amounts, or performance thresholds disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1123494/000117184323001577/0001171843-23-001577-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1123494/000117184323001577/f8k_031023.htm
  HTML page:      https://secwatch.observer/filing/0001171843-23-001577

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer